Search for: "Endo Pharmaceutical" Results 161 - 180 of 254
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2018, 2:06 pm by Dean I. Weitzman, Esq.
Also named in the lawsuit were Allergan, Cephalon, Teva Pharmaceuticals, Endo Health Solutions and Endo Pharmaceuticals, Janssen Pharmaceuticals, Johnson & Johnson and Purdue Frederick Co. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
24 Mar 2014, 10:39 am by Dr. Shezad Malik
., Androderm Endo Pharmaceuticals, Fortesta Testosterone Gel Auxilium Pharmaceuticals, Inc., Testim Testosterone Gel BioSante/Teva, Bio-T-Gel [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
13 Jul 2009, 7:46 pm
-based Endo Pharmaceuticals for $20 million up front and the potential for over $110 million more;  and Allostera raised $17 million in venture capital. [read post]
25 Jul 2012, 7:36 am by Craig Kelley
The lawsuit against Bard is just one in hundreds now being brought against makers of transvaginal mesh, including Bard, J&J, Boston Scientific Corp. and American Medical Systems of Endo Pharmaceutical Holdings Inc. [read post]
2 May 2014, 10:23 am by Ronald V. Miller, Jr.
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
18 Nov 2019, 4:24 am by Whittel & Melton, LLC
In recent lawsuits, the defendants have included McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, Covidien, Johnson & Johnson, CVS, Walgreens, and Rite Aid. [read post]
10 May 2012, 7:36 am by Kay Van Wey
Three pharmaceutical companies are being investigated in the Senate probe, including Purdue Pharma, Endo Pharmaceuticals, and Johnson & Johnson. [read post]
8 Oct 2009, 6:05 am
Reddy’s, Barr and Purepac (Patent Baristas) Renagel (Sevelamer) – US: Genzyme files patent infringement suit against Endo Pharmaceuticals following Para IV challenge (Patent Docs) Roundup Ready cotton seed – US: Monsanto files patent infringement suits against Brent M Hargrove and Larry H Lytle based on defendants’ use of cotton seed produced from earlier planted Roundup Ready cotton seed (Patent Docs) Seroquel (Quetiapine) – US:… [read post]
25 Jul 2012, 5:56 pm
The judge is overseeing evidence-gathering efforts in cases against Bard, J&J, Boston Scientific Corp. and the American Medical Systems unit of Endo Pharmaceutical Holdings Inc. [read post]
25 Jul 2012, 5:56 pm
The judge is overseeing evidence-gathering efforts in cases against Bard, J&J, Boston Scientific Corp. and the American Medical Systems unit of Endo Pharmaceutical Holdings Inc. [read post]
15 Sep 2011, 1:00 pm by info@thomasjhenrylaw.com
Johnson & Johnson and Endo Pharmaceuticals Holdings- More safety studies and labeling changes could help. [read post]
1 Jul 2014, 6:16 am by CSSFIRM.COM
Symptoms of low-T include: Loss of libido Decreased muscle mass Fatigue Products affected by the FDA request include AbbVie Inc’s AndroGel, Endo International Plc’s Aveed and Trimel Pharmaceuticals Corp’s Natesto. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
22 Jun 2011, 4:09 am by Marie Louise
(BIOtechNow) US: Manager’s Amendment (and others) to H.R. 1249 — Second opinions in genetic diagnostic testing (Patent Docs) US: AMA, ACLU and their friends oppose (Leahy-Smith) America Invents Act (Patent Docs) US: Kaneka files new 337 complaint regarding Certain Coenzyme Q10 Products (ITC 337 Law Blog) Products Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Cialis (Tadalafil)… [read post]